Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of DocGo Inc (NASDAQ: DCGO) closed at $1.15 in the last session, down -4.17% from day before closing price of $1.2. In other words, the price has decreased by -$4.17 from its previous closing price. On the day, 3.66 million shares were traded. DCGO stock price reached its highest trading level at $1.205 during the session, while it also had its lowest trading level at $1.12.
Ratios:
We take a closer look at DCGO’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.08 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 1.35. For the most recent quarter (mrq), Quick Ratio is recorded 2.36 and its Current Ratio is at 2.36. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.07.
On February 28, 2025, Deutsche Bank Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $5 to $2.85.
On August 18, 2023, BTIG Research started tracking the stock assigning a Buy rating and target price of $15.BTIG Research initiated its Buy rating on August 18, 2023, with a $15 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 23 ’25 when Burdiek Michael J bought 10,000 shares for $1.33 per share. The transaction valued at 13,300 led to the insider holds 641,560 shares of the business.
Burdiek Michael J bought 15,000 shares of DCGO for $21,450 on May 15 ’25. The Director now owns 631,560 shares after completing the transaction at $1.43 per share. On May 14 ’25, another insider, Klasko Stephen K. M.D., who serves as the Director of the company, bought 15,000 shares for $1.49 each. As a result, the insider paid 22,350 and bolstered with 15,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DCGO now has a Market Capitalization of 112479352 and an Enterprise Value of 59220580. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.26 while its Price-to-Book (P/B) ratio in mrq is 0.38. Its current Enterprise Value per Revenue stands at 0.136 whereas that against EBITDA is -4.364.
Stock Price History:
The Beta on a monthly basis for DCGO is 0.95, which has changed by -0.6493902 over the last 52 weeks, in comparison to a change of 0.118204355 over the same period for the S&P500. Over the past 52 weeks, DCGO has reached a high of $5.68, while it has fallen to a 52-week low of $1.18. The 50-Day Moving Average of the stock is -22.69%, while the 200-Day Moving Average is calculated to be -52.96%.
Shares Statistics:
According to the various share statistics, DCGO traded on average about 507.91K shares per day over the past 3-months and 1181610 shares per day over the past 10 days. A total of 97.76M shares are outstanding, with a floating share count of 84.92M. Insiders hold about 13.18% of the company’s shares, while institutions hold 47.77% stake in the company. Shares short for DCGO as of 1759190400 were 4547843 with a Short Ratio of 8.95, compared to 1756425600 on 4044233. Therefore, it implies a Short% of Shares Outstanding of 4547843 and a Short% of Float of 4.7399998.
Earnings Estimates
Current recommendations for the stock of the company come from 1.0 analysts. The consensus estimate for the next quarter is -$0.4, with high estimates of -$0.4 and low estimates of -$0.4.
Analysts are recommending an EPS of between -$1.17 and -$1.17 for the fiscal current year, implying an average EPS of -$1.17. EPS for the following year is -$0.74, with 1.0 analysts recommending between -$0.74 and -$0.74.
Revenue Estimates
According to 7 analysts,. The current quarter’s revenue is expected to be $69.96M. It ranges from a high estimate of $73.36M to a low estimate of $67.65M. As of. The current estimate, DocGo Inc’s year-ago sales were $138.68MFor the next quarter, 7 analysts are estimating revenue of $71.57M. There is a high estimate of $75.18M for the next quarter, whereas the lowest estimate is $68.51M.
A total of 7 analysts have provided revenue estimates for DCGO’s current fiscal year. The highest revenue estimate was $323.46M, while the lowest revenue estimate was $315.01M, resulting in an average revenue estimate of $317.98M. In the same quarter a year ago, actual revenue was $616.56MBased on 7 analysts’ estimates, the company’s revenue will be $316.56M in the next fiscal year. The high estimate is $336.25M and the low estimate is $297.6M.
